Clinical Trial Update: A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

View source ↗

Summary

A clinical trial assessing Adcetris (brentuximab vedotin) in adults with Hodgkin lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adcetris (Brentuximab vedotin)

Snippet

Sponsor: Takeda | Conditions: Hodgkin Lymphoma | Status: RECRUITING